OSSIO
Kevin Zenor is a seasoned sales professional with extensive experience in the medical device industry, currently serving as the Regional Sales Manager at OSSIO since January 2023. Previously, Kevin held various roles at ATX Medical Solutions as an Independent Medical Device Sales and Consultant from April 2019 to January 2023, and at Bioventus in positions including Director of Sales and Medical Device Sales Representative from December 2012 to April 2019. Prior to a focus on medical sales, Kevin gained retail management experience as a Store Manager at Dick's Sporting Goods and held multiple district management roles at Champs Sports. Kevin earned a Bachelor of Science degree in Kinesiology and Exercise Science from West Texas A&M University and has foundational education from Panhandle State University in the same field.
This person is not in any offices
OSSIO
OSSIO is an orthopedic fixation company committed to transforming the orthopedic experience for patients, physicians, and payors. Their vision is to provide the first credible replacement to metal implants in the $10B+ orthopedic fixation market (screws, pins, plates) with an Intelligent Bone Regeneration Technology. OSSIOfiber represents abreakthrough material platform for orthopedic and podiatric surgeons who seek a more biologically friendly way to restore patient stability and mobility with nothing permanent left behind.Founded in 2014, OSSIO began as the culmination of years of biomechanical research and a vision for the possibility of better bone healing. The technological basis of OSSIOfiber™ was developed and would lay the groundwork for ushering in a new breakthrough category of non-permanent fixation, “Bio-Integratives” hardware that has both desired strength AND bio-friendliness. Hardware that has the mechanical strength for easy insertion and secure fixation, while enabling the body to regrow bone, incorporating and replacing the implant (without the adverse inflammation and weakness often seen in “bio-resorbables and other “bio-composites”), has remained elusive to the industry until now.